Armata Pharmaceuticals, Inc. (ARMP)
NYSE
Closed
Oct 8, 2026
Day's Range
3.6052 wk Range
3.09Profile - ARMP - Armata Pharmaceuticals, Inc.
Profile
Mic Code
XASE
Sector
Healthcare
Industry
Biotechnology
Employees
61
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections. The company’s current work centers on phage-based medicines designed to target specific bacterial pathogens, with programs addressing infections such as Staphylococcus aureus bacteremia and Pseudomonas aeruginosa-related disease. Its platform combines natural and synthetic bacteriophages with proprietary engineering, microbiological surveillance, and drug development capabilities to support product design, manufacturing, and clinical testing. Armata Pharmaceuticals operates as a specialist in infectious disease therapeutics, serving an important role in the broader biopharmaceutical market by advancing alternative approaches to conventional antibiotics.
Profile Details
Type
Common Stock
Address
5005 McConnell Avenue
City
Los Angeles
State
CA
Zip
90066
Country
United States
Phone
310 665 2928
Key Executives - ARMP - Armata Pharmaceuticals, Inc.
Key executives
Cross Listings - ARMP - Armata Pharmaceuticals, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
